rems
Tag details
Welcome to the 'rems' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'rems'.
Look up
"rems"
at The Free Dictionary
Latest blogosphere posts tagged “rems”
-
(AUXL) Auxilium Pharmaceuticals’ Xiaflex Awarded FDA Approval
Stock Blog Hub —
Authority: 463
Auxilium Pharmaceuticals, Inc. ( AUXL ) recently received a major boost when the U.S. Food and Drug Administration (FDA) granted approval to Xiaflex for the treatment of adult Dupuytren’s contracture patients with a palpable cord. The approval comes several months after an FDA advisory panel voted unanimously in ...6 days ago -
A Trial Over Botox In Children With Cerebral Palsy
Pharmalot —
Authority: 554
A woman is suing Allergan, which makes Botox, because she believes the injectable cosmetic med led to the death of her seven-year-old daughter. Why? Botox was used to treat muscle spasms resulting from cerebral palsy, and Dee Spears charges Allergan wrongfully promoted untested and off-label uses, misrepresented Botox ...1 week ago -
(NVO) Novo Nordisk Earns US Food and Drug Administration for Diabetes Treatment
Stock Blog Hub —
Authority: 463
In a major breakthrough, Denmark based Novo Nordisk ( NVO ) received US Food and Drug Administration (FDA) approval for Victoza (liraglutide), a once-daily injection for the treatment of type II diabetes in adults. The drug has been approved for use with proper diet, exercise and other diabetes medicines for ...1 week ago -
(AMGN) Amgen’s Fourth Quarter Report Misses Expectations but Company Guides Higher
Stock Blog Hub —
Authority: 463
Amgen ( AMGN ) reported fourth quarter earnings per share of $1.03, well below the Zacks Consensus Estimate of $1.11 and a cent below the year-ago earnings of $1.04. Full year earnings came in at $4.83, 8 cents below the Zacks Consensus Estimate but 7.8% above the year-ago earnings of $4.48. While fourth quarter ...2 weeks ago -
Kaiser Petitions The FDA Over REMS Programs
Pharmalot —
Authority: 554
Worried that REMS programs may add to healthcare costs, Kaiser Permanente filed a citizen’s petition asking the FDA to take several steps to mitigate the effect of these programs, particularly a portion known Elements to Assure Safe Use, or ETASU. Kaiser claims the FDA failed to seek public input from patients or ...3 weeks ago


